RemSleep Holdings Inc (RMSL): Cytotoxicity tests to be redone accordin...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: ZetaReticuli post# 30605

Wednesday, 08/24/2022 8:35:25 AM

Wednesday, August 24, 2022 8:35:25 AM

Cytotoxicity tests to be redone according to this-shareholder-inquiry:

Keep Last Read

Next 10 Prev Next

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 05/29/2024 09:18:12 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/17/2024 09:11:25 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 07:23:42 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/14/2024 01:10:38 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/14/2024 05:15:18 AM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/02/2024 09:58:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 09:38:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/22/2023 08:26:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 07:02:41 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 10:10:55 AM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:12:01 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/14/2023 01:58:57 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2023 07:21:17 PM

InvestorsHub NewsWire

Only $200 per official company press release!